Ally Bridge Group (Ny) LLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $69.6 Million distributed in 24 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Verona Pharma PLC with a value of $15.2M, Compass Pathways PLC with a value of $12.7M, Merus N.V. with a value of $7.37M, Oric Pharmaceuticals, Inc. with a value of $4.93M, and Replimune Group, Inc. with a value of $4.91M.

Examining the 13F form we can see an decrease of $6.47M in the current position value, from $76.1M to 69.6M.

Ally Bridge Group (Ny) LLC is based out at New York, NY

Below you can find more details about Ally Bridge Group (Ny) LLC portfolio as well as his latest detailed transactions.

Portfolio value $69.6 Million
Healthcare: $69 Million

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 24
  • Current Value $69.6 Million
  • Prior Value $76.1 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 9 stocks
  • Additional Purchases 9 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 5 stocks
Track This Portfolio

Track Ally Bridge Group (Ny) LLC Portfolio

Follow Ally Bridge Group (Ny) LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.